Reata Pharmaceuticals, Inc. EPS - Earnings per Share 2016-2023 | RETA
Reata Pharmaceuticals, Inc. eps - earnings per share from 2016 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Reata Pharmaceuticals, Inc. Annual EPS |
| 2022 |
$-8.54 |
| 2021 |
$-8.19 |
| 2020 |
$-7.35 |
| 2019 |
$-9.54 |
| 2018 |
$-2.91 |
| 2017 |
$-1.99 |
| 2016 |
$-0.31 |
| 2015 |
$-0.09 |
| 2014 |
$0.04 |
| Reata Pharmaceuticals, Inc. Quarterly EPS |
| 2023-06-30 |
$4.65 |
| 2023-03-31 |
$-3.14 |
| 2022-12-31 |
$-2.33 |
| 2022-09-30 |
$-2.16 |
| 2022-06-30 |
$-2.02 |
| 2022-03-31 |
$-2.03 |
| 2021-12-31 |
$-2.36 |
| 2021-09-30 |
$-1.97 |
| 2021-06-30 |
$-2.00 |
| 2021-03-31 |
$-1.86 |
| 2020-12-31 |
$-1.91 |
| 2020-09-30 |
$-1.94 |
| 2020-06-30 |
$-2.03 |
| 2020-03-31 |
$-1.47 |
| 2019-12-31 |
$-6.10 |
| 2019-09-30 |
$-1.32 |
| 2019-06-30 |
$-1.14 |
| 2019-03-31 |
$-0.98 |
| 2018-12-31 |
$-0.91 |
| 2018-09-30 |
$-1.07 |
| 2018-06-30 |
$-1.08 |
| 2018-03-31 |
$0.15 |
| 2017-12-31 |
$-0.65 |
| 2017-09-30 |
$-0.50 |
| 2017-06-30 |
$-0.52 |
| 2017-03-31 |
$-0.32 |
| 2016-12-31 |
$-0.20 |
| 2016-09-30 |
$-0.04 |
| 2016-06-30 |
$-0.05 |
| 2016-03-31 |
$-0.02 |
| 2015-12-31 |
$-0.10 |
| 2015-09-30 |
$0.04 |
| 2015-06-30 |
$-0.11 |
| 2015-03-31 |
$0.08 |
